✦ LIBER ✦

A review of “upfront” chemotherapy in invasive transitional cell carcinoma of the bladder

✍ Scribed by F. M. J. Debruyne; T. A. W. Splinter

Publisher: Springer-Verlag
Year: 1988
Tongue: English
Weight: 335 KB
Volume: 6
Category: Article
ISSN: 0724-4983
DOI: 10.1007/bf00326795

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radiation therapy and concomitant paclit

Radiation therapy and concomitant paclitaxel/carboplatin chemotherapy for muscle invasive transitional cell carcinoma of the bladder: A well-tolerated combination

✍ R. Charles Nichols Jr.; Matthew G. Sweetser; Syed K. Mahmood; Fernando C. Malamu 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 207 KB 👁 2 views

Analysis of failure following definitive

Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder

✍ Hedy Mameghan; Richard Fisher; Jill Mameghan; Susan Brook 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Analysis of failure following definitive

Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder

✍ Hedy Mameghan; Richard Fisher; Jill Mameghan; Susan Brook 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 821 KB

Transitional cell papillary carcinoma of

Transitional cell papillary carcinoma of the bladder in a child

✍ B. Lalmand; E. F. Avni; J. Simon; A. Verhest; C. C. Schulman; J. Struyven 📂 Article 📅 1987 🏛 Springer-Verlag 🌐 English ⚖ 360 KB

Combined radiation and chemotherapy for

Combined radiation and chemotherapy for locally advanced transitional cell carcinoma of the urinary bladder

✍ Gerhard Jakse; Herman Frommhold; Dieter Zur Nedden 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 528 KB

Systemic chemotherapy of transitional ce

Systemic chemotherapy of transitional cell carcinoma of the urothelium

✍ William M. Brinkley; Frank M. Torti 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 3 views

Although the incidence of bladder cancer has increased in recent years, survival has also improved. Chemotherapy has made a substantial impact on this disease and now is used in patients with advanced or metastatic disease as well as in select patients with high-risk muscle invasive disease. While c